Authors
Sam Abdelghany, PharmD, is an executive director of oncology pharmacy at Smilow Cancer Hospital at Yale-New Haven Health.
Jennifer Payton, MHCA, BSN, RN, CNN, is president of the American Nephrology Nurses Association.
Andrey Ostrovsky, MD, FAAP, was the former chief medical officer of the US Medicaid program. He is the managing partner at Social Innovation Ventures, where he invests in and advises companies and nonprofits dedicated to eliminating disparities. He also advises federal and state regulators on how to incorporate human-centered design into policymaking.
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
3
Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD
4
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
5

